| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8537781 | Pulmonary Pharmacology & Therapeutics | 2018 | 27 Pages |
Abstract
Nintedanib demonstrated an acceptable safety and efficacy profile in our real-world observational study. Prospective observational studies in the context of registries that collect well-defined supporting data over time are sorely needed to answer residual questions on drug's performance.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Argyrios Tzouvelekis, Theodoros Karampitsakos, Maria Kontou, Andreas Granitsas, Ioanna Malliou, Aris Anagnostopoulos, Paschalis Ntolios, Vasilios Tzilas, Evangelos Bouros, Paschalis Steiropoulos, Serafeim Chrysikos, Katerina Dimakou, Nikolaos Koulouris,